General Atlantic Portfolio
Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.
Adagene is a clinical-stage biotechnology company focused on developing innovative antibodies with superior safety and efficacy profiles.
Ocumension is a clinical-stage biotechnology platform company focused on developing and commercializing innovative ophthalmology therapeutics in China.
Futu is a leading online brokerage platform, providing cost-effective, mobile-based online brokerage services to clients in China and Hong Kong.